KVGBA05HH1

Hydrophobic Durapore^® 0.22 µm, Opticap^® XL Capsule

Opticap^® XL 5, inlet connection diam. 9/16 in., pore size 0.22 μm, cartridge nominal length 5 in. (12.5 cm)

• Synonim(y): Opticap Sterilizing Grade XL5 Durapore Hydrophobic 0.22 µm 9/16 in. HB/HB
• Kod UNSPSC: 23151806

Właściwości

• Materiały: PVDF ; polypropylene ; polypropylene housing; polypropylene support; polypropylene vent cap; silicone seal
• Poziom jakości: 400
• zgodność regionalna: meets FDA Indirect Food Additive requirements cited in 21 CFR 177-182 (all component materials)
• sterylność: non-sterile
• Kompatybilność ze sterylizacją: autoclavable compatible
• linia produktu: Opticap^® XL 5
• Właściwości: hydrophobic
• producent / nazwa handlowa: Opticap^®
• Parametry: ≤5 mL/min nitrogen diffusion at 1.7 bar (25 psig) and 23 °C (in 60/40% IPA/water); 1.0 bar max. differential pressure (15 psid) at 80 °C (Forward); 1.0 bar max. inlet pressure (15 psi) at 80 °C; 2.8 bar max. inlet pressure (40 psi) at 60 °C; 25 °C max. inlet temp.; 3.4 bar max. differential pressure (50 psid) at 25 °C (Reverse; intermittent); 5.5 bar max. differential pressure (80 psid) at 25 °C (Forward); 5.5 bar max. inlet pressure (80 psi) at 23 °C; 80 psig max. inlet pressure
• metody: sterile filtration: suitable
• Długość: 8.4 in.
• Szerokość: 5.7 in.
• długość nominalna kartridża: 5 in. (12.5 cm)
• Średnica: 14.5 cm (5.7 in.)
• powierzchnia filtracyjna: 0.35 m²
• śr. przyłącza doprowadzającego: 9/16 in.
• szer. od złącza doprowadzającego do złącza odprowadzającego: 21.3 cm (8.4 in.)
• śr. przyłącza odprowadzającego: 9/16 in.
• zanieczyszczenia: ≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction); <0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
• Matryca: Durapore^®
• wielkość porów: 0.22 μm pore size
• punkt pęcherzykowania: ≥1170 mbar (17 psig), nitrogen with 60/40% IPA/water at 23 °C
• dopasowywanie: 1/4 in. drain/vent hose barb (with double O-ring Seal); (14 mm (9/16 in.) Hose Barb Inlet and Outlet)

Opis

Opis ogólny

Device Configuration: Capsule

Opakowanie

Double Easy-Open bag

Inne uwagi

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Directions for Use

• Organism Retention: Microorganism
• Mode of Action: Filtration (size exclusion)
• Application: BioProcessing
• Intended Use: Reduction or removal of microorganism/bioburden
• Instructions for Use: Please refer installation section of OPTICAP^® XL Capsules and OPTICAP^® XLT Capsules user guide
• Storage Statement: Store in dry location
• Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.

Uwaga dotycząca przygotowania

Sterilization Method
20 autoclave cycles of 30 min @ 126 °C; not in-line steam sterilizable

This product was manufactured with a Durapore^® membrane which meets the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).

Komentarz do analizy

Bacterial Retention
Samples were quantitatively retentive of a minimum Brevundimonas diminuta challenge concentration of 1 x 10⁷ CFU/cm² using ASTM^® F838 methodology.

Informacje prawne

ASTM is a registered trademark of American Society for Testing and Materials

Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany

OPTICAP is a registered trademark of Merck KGaA, Darmstadt, Germany

Oświadczenie o zrzeczeniu się odpowiedzialności

EMD Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 3 § 3 of this Pressure Vessel Directive, this product does not bear the CE mark.

Ta strona może zawierać tekst przetłumaczony maszynowo.